Assessment of Financial Difficulty in Participants With Chronic Lymphocytic Leukemia and Multiple Myeloma

Overview

This trial studies financial difficulty in participants with chronic lymphocytic leukemia and multiple myeloma. Assessment of financial difficulty may help to better understand the financial impact of cancer and come up with ways to help participants avoid financial problems during treatment.

SparkCures ID 1030
Trial Phase Observational Trial
Enrollment 500 Patients
Trial Sponsors
  • Alliance for Clinical Trials in Oncology
Trial Collaborators
  • National Cancer Institute (NCI)
  • Leukemia and Lymphoma Society
NCT Identifier

NCT03870633

Am I Eligible?

The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.

The following criteria is provided for health care professionals.

Inclusion Criteria:

PATIENT ELIGIBILITY CRITERIA

  • Patients must have current diagnosis of chronic lymphocytic leukemia (CLL) or multiple myeloma (MM)
  • Patients' medical records must be available to the registering institution
  • Eligible patients must have been prescribed drug-based anticancer therapy, whether administered orally or by infusion, within the prior 12 months. Specifically, eligible patients are those who:
    • Are presently being treated with infused or orally-administered anticancer therapy, OR
    • Completed infused or orally-administered anti-cancer therapy in the past 12 months, OR
    • Were prescribed infused or orally-administered anticancer therapy within the prior 12 months yet chose to forego treatment
  • Not currently enrolled in a clinical trial in which drug is supplied by the study
  • Patients with psychiatric illness or other mental impairment that would preclude their ability to give informed consent or to respond to the telephone survey are not eligible
  • Patients must be able to read and comprehend English or Spanish

US Trial Locations

Not Currently Accepting Patients

The following is a listing of trial locations that are not currently open and accepting patients.

Medical Oncology and Hematology Associates (Laurel)

Des Moines, IA

Broadlawns Medical Center

Des Moines, IA

Saint John's Hospital - Healtheast

Maplewood, MN

Park Nicollet Clinic (Saint Louis Park)

St. Louis Park, MN

Regions Hospital

St. Paul, MN

Lakeview Hospital

Stillwater, MN

Mission Hospital Inc - Memorial Campus

Asheville, NC

Southern Ohio Medical Center

Portsmouth, OH

Greenville Health System Cancer Institute-Laurens -

Clinton, SC

Greenville Health System Cancer Institute

Easley, SC

Greenville Health System Cancer Institute-Butternut

Greenville, SC

Greenville Health System Cancer Institute-Faris

Greenville, SC

Greenville Health System Cancer Institute-Eastside

Greenville, SC

Greenville Health System Cancer Institute

Greenville, SC

Greenville Health System Cancer Institute

Seneca, SC

Greenville Health System Cancer Institute

Spartanburg, SC

Iowa
Medical Oncology and Hematology Associates (Laurel)

Des Moines, IA

Broadlawns Medical Center

Des Moines, IA

Minnesota
Saint John's Hospital - Healtheast

Maplewood, MN

Park Nicollet Clinic (Saint Louis Park)

St. Louis Park, MN

Regions Hospital

St. Paul, MN

Lakeview Hospital

Stillwater, MN

North Carolina
Mission Hospital Inc - Memorial Campus

Asheville, NC

Ohio
Southern Ohio Medical Center

Portsmouth, OH

South Carolina
Greenville Health System Cancer Institute-Laurens -

Clinton, SC

Greenville Health System Cancer Institute

Easley, SC

Greenville Health System Cancer Institute-Butternut

Greenville, SC

Greenville Health System Cancer Institute-Faris

Greenville, SC

Greenville Health System Cancer Institute-Eastside

Greenville, SC

Greenville Health System Cancer Institute

Greenville, SC

Greenville Health System Cancer Institute

Seneca, SC

Greenville Health System Cancer Institute

Spartanburg, SC

Resources

There are no resources, links or videos to display for this clinical trial.